Home The arginine stimulation test: timing of peak is not a helpful parameter in the diagnosis of growth hormone deficiency
Article
Licensed
Unlicensed Requires Authentication

The arginine stimulation test: timing of peak is not a helpful parameter in the diagnosis of growth hormone deficiency

  • David Gillis EMAIL logo , Nadav Granat and David Strich
Published/Copyright: May 24, 2013

Abstract

Background: A typical peak timing in the glucagon stimulation test has been reported as an indication of growth hormone (GH) deficiency. Other stimulation tests have not been evaluated.

Objective: To evaluate the clinical usefulness of peak timing in the arginine stimulation test (AST) for growth hormone deficiency.

Methods: Retrospective review of 199 ASTs from one center. Outcomes included correlation of peak times with (a) frequency of deficient peak; (b) growth velocity standard deviation scores (GVSDSs); (c) other evidence of pituitary pathology; (d) results of confirmatory clonidine test; and (e) response to GH treatment.

Results: The peak in 83/109 (76.14%) sufficient tests occurred at typical times vs. 45/72 (62.5%) deficient tests (p<0.05). GVSDS on GH treatment was greater among patients with typical timing in the AST compared with atypical timing (2.67±0.59 vs. 0.46±1.17, p=0.021). No other variable correlated significantly with AST timing.

Conclusions: Timing of peak in the AST is not a clinically useful parameter.


Corresponding author: Dr. David Gillis, Department of Pediatrics, Hadassah University Hospital, Ein-Kerem, Jerusalem, Israel, Phone: +972 507874572; Fax: +972 26434579, E-mail:

References

1. Ranke MB. Diagnosis of growth hormone deficiency and growth hormone stimulation tests. In: Ranke MB, editor. Diagnostic of endocrine function in children and adolescents, 3rd ed. Basel: Karger, 2003:107–28.Search in Google Scholar

2. Israel Association of Pediatric Endocrinology Committee on Growth Hormone Diagnosis and Treatment. Clinical guidelines; diagnosis and management of growth hormone deficiency. Tel Aviv: Israel Medical Association Publications, 1999:1–10.Search in Google Scholar

3. Muster L, Zangen DH, Nesher R, Hirsch HJ, Muster Z, et al. Arginine and clonidine stimulation tests for growth hormone deficiency revisited; do we really need so many samples? J Pediatr Endocrinol Metab 2009;22:215–23.10.1515/JPEM.2009.22.3.215Search in Google Scholar

4. Merimme T, Lillicrap DA. Rabinowits D. Effect of arginine on serum levels of human growth-hormone. Lancet 1965;7414:668–70.10.1016/S0140-6736(65)90399-5Search in Google Scholar

5. Parker ML, Hammond JM, Daughaday WH. The arginine provocative test: an aid in the diagnosis of hyposomatropism. J Clin Endocrinol 1967;27:1129–36.10.1210/jcem-27-8-1129Search in Google Scholar PubMed

6. Strich D, Terespolsky N, Gillis D. Glucagon stimulation test for childhood growth hormone deficiency: timing of the peak is important. J Pediatr 2009;154:415–9.10.1016/j.jpeds.2008.08.044Search in Google Scholar PubMed

7. Trainer PJ, Barth J, Sturgeon C, Wieringaon G. Consensus statement on the standardization of GH assays. Eur J Endocrinol 2006;155:1–2.10.1530/eje.1.02186Search in Google Scholar PubMed

8. Eliakim A, Brasel JA, Cooper DM. GH response to exercise: assessment of the pituitary refractory period, and relationship with circulating components of the GH-IGF-I axis in adolescent females. J Pediatr Endocrinol Metab 1999;12:47–55.10.1515/JPEM.1999.12.1.47Search in Google Scholar

9. Svensson J, Johannsson G, Iranmanesh A, Albertsson-Wikland K, Veldhuis JD, et al. GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood. Eur J Endocrinol 2006;155:91–9.10.1530/eje.1.02182Search in Google Scholar PubMed

10. Svensson J, Veldhuis JD, Iranmanesh A, Bengtsson BA, Johannsson G. Increased orderliness of growth hormone (GH) secretion in GH-deficient adults with low serum insulin-like growth factor I. J Clin Endocrinol Metab 2002;87:2863–9.10.1210/jcem.87.6.8566Search in Google Scholar PubMed

11. Zeniou-Meyer M, Zabari N, Ashery U, Chasserot-Golaz S, Haeberlé AM, et al. Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage. J Biol Chem 2007;282:21746–57.10.1074/jbc.M702968200Search in Google Scholar PubMed

12. Rogol A, Blethen SL, Sy J, Veldhuist. Do growth hormone (GH) serial sampling, insulin-like growth factor-1 (IGF-1) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy? Clin Endocrinol 2003;58:229–337.10.1046/j.1365-2265.2003.01701.xSearch in Google Scholar PubMed

Received: 2013-2-24
Accepted: 2013-4-30
Published Online: 2013-05-24
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review
  5. Images in pediatric endocrinology
  6. Solitary median maxillary central incisor, a clinical predictor of hypoplastic anterior pituitary, ectopic neurohypophysis and growth hormone deficiency
  7. A rare case of granuloma annulare in a 6-year-old child with type 1 diabetes
  8. Original articles
  9. The arginine stimulation test: timing of peak is not a helpful parameter in the diagnosis of growth hormone deficiency
  10. The relationship between adiposity and stature in prepubertal children with celiac disease
  11. Influence of micronutrient status and socioeconomic gradient on growth indices of 2–18-year-old Indian girls
  12. Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature
  13. The relation between salivary cortisol and the metabolic syndrome score in girls
  14. Association of vitamin D concentrations with adiposity indices among preadolescent children in Korea
  15. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children
  16. Characteristics of infants at risk of hypoglycaemia secondary to being ‘infant of a diabetic mother’
  17. Parental dyadic coping in families of children and adolescents with type 1 diabetes
  18. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome
  19. Effect of insulin therapy on IGF-1 level in children with new-onset type 1 diabetes mellitus: a comparison between DKA and non-DKA
  20. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias
  21. Sexual development in prepubertal obese boys: a 4-year longitudinal study
  22. Genetic diagnosis of one family with incomplete clinical data
  23. Patient reports
  24. Complete androgen insensitivity syndrome and discordant Müllerian remnants: two cases with novel mutation in the androgen receptor
  25. Psychosexual outcomes in three siblings with partial androgen insensitivity syndrome: impact of nature versus nurture
  26. Ambiguous genitalia in a 48, XXYY newborn: a casual relationship or a coincidence?
  27. Gonadal function of beta-thalassemics following stem cell transplantation conditioned with myeloablative and reduced intensity regimens
  28. Significant testicular enlargement in a 6.5-year-old boy with monorchism and testicular microlithiasis
  29. Report of the first case of precocious puberty in Rett syndrome
  30. Type II vitamin D-dependent rickets with diabetic ketoacidosis
  31. Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent
  32. A rare association between Rathke’s cyst and hypophysitis in a patient with delayed sex development and growth failure
  33. Diabetes mellitus with Laron syndrome: case report
  34. Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood
  35. Rare cases of autoimmune hypothyroidism in young children
  36. Cushing syndrome related to leukemic infiltration of the central nervous system: a case report and a possible role of LIF
  37. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy
  38. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease
  39. Virilization in two pre-pubertal children exposed to topical androgen
  40. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands
  41. Short communications
  42. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes
  43. Assessment of contractility and myocardial function in small and appropriate for gestational age premature neonates using the stress-velocity relationship and tissue Doppler imaging immediately after birth
  44. Letter to the Editors
  45. Homeostasis model assessment of insulin resistance may not be reliable to evaluate insulin sensitivity in young obese children
  46. Type 1 diabetes in women with endometriosis: what is the risk of occurrence?
  47. How should we manage vitamin D-deficient adolescents?
  48. Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically?a
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0075/html
Scroll to top button